☰

Eileen S. Carpenter, Ph.D. - Publications

Affiliations: 
2013 Molecular and Cellular Pharmacology Stony Brook University, Stony Brook, NY, United States 
Area:
Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yan W, Menjivar RE, Bonilla ME, Steele NG, Kemp SB, Du W, Donahue KL, Brown K, Carpenter ES, Avritt FR, Irizarry-Negron VM, Yang S, Burns WR, Zhang Y, Pasca di Magliano M, et al. Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer. Cancer Immunology Research. PMID 37931247 DOI: 10.1158/2326-6066.CIR-23-0037  0.417
2023 Carpenter ES, Kadiyala P, Elhossiny AM, Kemp SB, Li J, Steele NG, Nicolle R, Nwosu ZC, Freeman J, Dai H, Paglia D, Du W, Donahue K, Morales J, Medina-Cabrera PI, et al. KRT17High/CXCL8+ tumor cells display both classical and basal features and regulate myeloid infiltration in the pancreatic cancer microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37851080 DOI: 10.1158/1078-0432.CCR-23-1421  0.398
2023 Menjivar RE, Nwosu ZC, Du W, Donahue KL, Hong HS, Espinoza C, Brown K, Velez-Delgado A, Yan W, Lima F, Bischoff A, Kadiyala P, Salas-Escabillas D, Crawford HC, Bednar F, ... Carpenter E, et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Elife. 12. PMID 36727849 DOI: 10.7554/eLife.80721  0.653
2023 Yan W, Steele NG, Kemp SB, Menjivar RE, Du W, Carpenter ES, Donahue KL, Brown KL, Irizarry-Negron V, Yang S, Burns WR, Zhang Y, di Magliano MP, Bednar F. Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer. Biorxiv : the Preprint Server For Biology. PMID 36711890 DOI: 10.1101/2023.01.11.523584  0.416
2022 Du W, Menjivar RE, Donahue KL, Kadiyala P, Velez-Delgado A, Brown KL, Watkoske HR, He X, Carpenter ES, Angeles CV, Zhang Y, Pasca di Magliano M. WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer. The Journal of Experimental Medicine. 220. PMID 36239683 DOI: 10.1084/jem.20220503  0.425
2022 Mello AM, Ngodup T, Lee Y, Donahue KL, Li J, Rao A, Carpenter ES, Crawford HC, Pasca di Magliano M, Lee KE. Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer. Oncogenesis. 11: 56. PMID 36109493 DOI: 10.1038/s41389-022-00434-2  0.629
2022 Kadiyala P, Elhossiny AM, Carpenter ES. Using Single Cell Transcriptomics to Elucidate the Myeloid Compartment in Pancreatic Cancer. Frontiers in Oncology. 12: 881871. PMID 35664793 DOI: 10.3389/fonc.2022.881871  0.375
2021 Kremer DM, Nelson BS, Lin L, Yarosz EL, Halbrook CJ, Kerk SA, Sajjakulnukit P, Myers A, Thurston G, Hou SW, Carpenter ES, Andren AC, Nwosu ZC, Cusmano N, Wisner S, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nature Communications. 12: 4860. PMID 34381026 DOI: 10.1038/s41467-021-24859-2  0.557
2021 Kemp SB, Carpenter ES, Steele NG, Donahue KL, Nwosu ZC, Pacheco A, Velez-Delgado A, Menjivar RE, Lima F, The S, Espinoza CE, Brown K, Long D, Lyssiotis CA, Rao A, et al. Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-kB-mediated production of CXCL1. Cancer Research. PMID 34049975 DOI: 10.1158/0008-5472.CAN-20-3929  0.617
2021 Kemp SB, Steele NG, Carpenter ES, Donahue KL, Bushnell GG, Morris AH, The S, Orbach SM, Sirihorachai VR, Nwosu ZC, Espinoza C, Lima F, Brown K, Girgis AA, Gunchick V, et al. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages. Life Science Alliance. 4. PMID 33782087 DOI: 10.26508/lsa.202000935  0.6
2021 Steele NG, Biffi G, Kemp SB, Zhang Y, Drouillard D, Syu LJ, Hao Y, Oni TE, Brosnan E, Elyada E, Doshi A, Hansma C, Espinoza C, Abbas A, The S, ... ... Carpenter ES, et al. Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33495315 DOI: 10.1158/1078-0432.CCR-20-3715  0.612
2020 Steele NG, Carpenter ES, Kemp SB, Sirihorachai V, The S, Delrosario L, Lazarus J, Amir ED, Gunchick V, Espinoza C, Bell S, Harris L, Lima F, Irizarry-Negron V, Paglia D, et al. Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer. Nature Cancer. 1: 1097-1112. PMID 34296197 DOI: 10.1038/s43018-020-00121-4  0.603
2020 Carpenter ES, Steele NG, Pasca di Magliano M. Targeting the Microenvironment to Overcome Gemcitabine Resistance in Pancreatic Cancer. Cancer Research. 80: 3070-3071. PMID 32753486 DOI: 10.1158/0008-5472.Can-20-1692  0.454
2020 Zhang Y, Lazarus J, Steele NG, Yan W, Lee HJ, Nwosu ZC, Halbrook CJ, Menjivar RE, Kemp SB, Sirihorachai V, Velez-Delgado A, Donahue K, Carpenter ES, Brown KL, Irizarry-Negron V, et al. Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. Cancer Discovery. PMID 31911451 DOI: 10.1158/2159-8290.Cd-19-0958  0.687
2020 Carpenter E, Steele N, Kemp S, Sirihorachai V, Delrosario L, Gunchick V, Donahue K, Rao A, Anderson MA, Crawford H, Frankel T, Bednar F, Magliano MPD. Sa1422 USING ENDOSCOPIC FINE NEEDLE BIOPSIES TO MAP THE IMMUNE LANDSCAPE IN HUMAN PANCREATIC CANCER Gastrointestinal Endoscopy. 91. DOI: 10.1016/J.Gie.2020.03.1155  0.598
2019 Zhang Y, Lazarus J, Steele N, Lee H, Yan W, Halbrook CJ, Menjivar R, Kemp SB, Sirihoracai V, Carpenter ES, Nevison AC, Vinta A, Anderson MA, Crawford HC, Lyssiotis CA, et al. Abstract I04: Regulatory T-cell depletion causes compensatory immune suppression and accelerates pancreatic carcinogenesis Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-I04  0.684
2019 Zhang Y, Lazarus J, Steele N, Yan W, Lee H, Halbrook CJ, Menjivar R, Kemp SB, Sirihorachai V, Carpenter ES, Nevison AC, Vinta A, Anderson MA, Crawford HC, Lyssiotis CA, et al. Abstract A62: Regulatory T-cell depletion promotes oncogenic Kras-driven pancreatic carcinogenesis Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A62  0.696
2019 Steele N, Kemp S, Irizarry-Negron V, Sirihorachai V, Abbas A, Carpenter E, Halbrook C, Espinoza C, Lyssiotis C, Crawford H, Frankel T, Bednar F, Allen B, Magliano MPd. Abstract A52: Modulation of Hedgehog signaling alters immune infiltration in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A52  0.691
2019 Kemp S, Steele N, Carpenter E, Sirihorachai V, Bushnell G, Morris A, Espinoza C, Lima F, Nwosu Z, Orbach S, Shea L, Bednar F, Crawford H, Magliano MPd. Abstract A25: Using biomaterial scaffolds to study the genesis of the immunosuppressive premetastatic niche in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A25  0.655
2019 Carpenter E, Steele N, Sirihorachai V, Kemp S, Delrosario L, Frankel T, Crawford H, Anderson MA, Magliano MPD. Sa1707 – Using Endoscopic Fine Needle Biopsies of Pancreatic Ductal Adenocarcinoma for Immunotherapy Precision Medicine Gastroenterology. 156: S-373. DOI: 10.1016/S0016-5085(19)37774-1  0.6
2015 Takeuchi KK, Carpenter E, Wu C, Halbrook CJ, Lin RZ, Crawford HC. Abstract A04: PI3K regulation of RAC1 is required for Kras-induced pancreatic tumorigenesis Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A04  0.702
2014 Wu CY, Carpenter ES, Takeuchi KK, Halbrook CJ, Peverley LV, Bien H, Hall JC, DelGiorno KE, Pal D, Song Y, Shi C, Lin RZ, Crawford HC. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Gastroenterology. 147: 1405-16.e7. PMID 25311989 DOI: 10.1053/J.Gastro.2014.08.032  0.73
2012 Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 22: 304-17. PMID 22975374 DOI: 10.1016/J.Ccr.2012.07.024  0.588
2010 Bombardelli L, Carpenter ES, Wu AP, Alston N, DelGiorno KE, Crawford HC. Pancreas-specific ablation of beta1 integrin induces tissue degeneration by disrupting acinar cell polarity. Gastroenterology. 138: 2531-40, 2540.e1-4. PMID 20188101 DOI: 10.1053/J.Gastro.2010.02.043  0.703
Show low-probability matches.